Home > Healthcare > Medical Devices > Diagnostic Devices > Enteric Disease Testing Market

Enteric Disease Testing Market Trends

  • Report ID: GMI4024
  • Published Date: Feb 2024
  • Report Format: PDF

Enteric Disease Testing Market Trends

Growing trend towards the adoption of molecular diagnostics technique, surging demand for point-of-care testing, rise in foodborne illness surveillance, increasing need for integrated automation and robotics, and growing trends for personalized medicine and host response testing, among other factors are propelling the industry growth.
 

  • There is a growing trend in intestinal disease testing to incorporate molecular diagnostic techniques such as PCR technologies and nucleic acid amplification tests (NAATs). Molecular approaches provide greater sensitivity, specificity, and rapid detection of enteric infections than classic culture-based methods, thus to their increased usage in clinical laboratories and healthcare settings.
     
  • Moreover, laboratory automation and robotic systems are being increasingly integrated into enteric disease testing workflows to streamline sample processing, improve testing throughput, and reduce turnaround times. Automated platforms for sample preparation, nucleic acid extraction, and assay setup enhance testing efficiency, minimize manual errors, and optimize laboratory resources.
Authors: Mariam Faizullabhoy , Gauri Wani

Frequently Asked Questions (FAQ) :

Enteric disease testing industry size reached USD 3.7 billion in 2023 and is set to expand at 3.9% CAGR from 2024-2032 driven by the rising prevalence of enteric diseases, growing concerns about food safety, and increasing healthcare expenditure and awareness across the globe.

Enteric disease testing industry from the immunoassay segment is anticipated to witness high demand accounting for USD 1.9 billion in revenue by 2032 as they provide rapid results compared to traditional culture-based methods or molecular diagnostics.

North America enteric disease testing industry size generated USD 1.4 billion in 2023 and is set to expand at a robust CAGR through 2032 owing to the presence of a sophisticated healthcare infrastructure, cutting-edge laboratory facilities, and well-equipped clinical microbiology laboratories.

Some of the leading enteric disease testing companies are Abbott Laboratories, Becton, Dickinson, and Company, Biomerica, Inc., BIOMÉRIEUX S.A, Bio, Rad Laboratories, Inc., Cepheid, DiaSorin S.p.A., Eurofins Scientific SE, Merck KGaA, Meridian Bioscience, and Quest Diagnostics Incorporated.

Enteric Disease Testing Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 12
  • Tables & Figures: 397
  • Countries covered: 22
  • Pages: 228
 Download Free Sample